If and when it receives FDA approval, the labeling will almost certainly adopt identical thresholds
Pankreas iltihab, yani pankreatit, bu ilalarla ilikilendirilen nemli bir risk olarak kabul edilir
Dapagliflozin reduced the composite of cardiovascular death and hospitalization for heart failure versus placebo with an additional benefit in the subgroup with baseline use of GLP-1RAs
I hold space for those feelings, and help you build body respect even if body positivity feels out of reach
This information should be interpreted alongside clinical biomarkers, not as a predictor of exact medication response, to support more personalized treatment planning
Individuals with a history of nephrolithiasis should be counseled to avoid high oxalate foods, highly processed foods, and animal-source proteins [[112], [113], [114]]